Search results

Selected filters:

Law & Policy

Article type





1,239 results found for your search

Sort options
01 November 2018

The four big trends that will transform life sciences patent strategies

As pharmaceutical R&D increasingly relies on interoperability, connectivity and data sharing, the way in which life sciences companies approach IP will have to change

30 October 2018

US firms banned from dealing with Chinese chipmaker accused of IP theft

Department of Commerce hits Fujian Jinhua with potentially crippling export ban amid its patent and trade secret battle with Micron. Unlike similar penalty against ZTE, this measure is clearly linked to IP theft accusations.

29 October 2018

Cautious no more, Iancu sets out his stall

In taking on the big beasts of Silicon Valley so directly, the USPTO director is gambling that he can change the patent narrative they have helped to create

26 October 2018

Amplified patent expertise could help SCOTUS dispel credibility doubts

Clerks hired by Justice Gorsuch have the kind of deep-rooted knowledge that may change minds among critical members of the IP bar

23 October 2018

New initiative can help answer patent system criticisms, says Novartis’ IP policy chief

In an exclusive interview with IAM, Corey Salsberg sung the praises of the Pat-INFORMED database and predicted more to come for the platform

22 October 2018

New PTAB decision looks like a good result for third-party IPR filers

Just months after Federal Circuit came down hard on RPX, Board's institution of a Unified review petition offers further guidance on determining real-party-in-interest

22 October 2018

Trade secret worries stall $4.1bn Chinese acquisition in Chile

Stake in mining giant would shore up China’s position in the battery tech supply chain. But top shareholder tells Chile’s highest court that the investment could result in loss of trade secrets.

16 October 2018

JPO will turn its attention to litigation reform

With big ADR push behind it, office asks firms to weigh in on whether courts provide sufficient IP protection. Commissioner Naoko Munakata previewed the initiative in recent remarks at IPBC Japan.

12 October 2018

Trump signs law that subjects all biosimilar patent settlements to FTC scrutiny

Heightened concern over pay-for-delay strategies has driven the legislation at a time when the number of biosimilars being approved is set to rise sharply

11 October 2018

Draft guidelines on 5G patent licensing draw stinging response from implementers

Six licensing principles have been made public by a group including Nokia, Ericsson and Qualcomm following work done with European standards organisations CEN and CENELEC 

11 October 2018

China may be reaching peak patent - or maybe not

On the face of it, the rise in annual filings by Chinese entities was the lowest since 1995 last year; but that may not be the full story. CNIPA points to a change in counting methodology, which only raises more questions.

09 October 2018

In US Senate antitrust hearing, key legislator puts himself in the IP spotlight

Senator homes in on divergent views between key agencies on FRAND licensing and risks to development of key technologies

08 October 2018

Life sciences innovators to gain from “new NAFTA”, but not immediately

The recently-struck deal promises to boost IP protection for pharma innovators in North America, but it will be years until it has an impact

02 October 2018

Will China’s leaders get to grips with the patent incentive problem?

A state media article blasts ‘fast food-style innovation’ as abandonments data paints a bleak picture.

02 October 2018

<em>Je ne regrette rien</em> – Battistelli, the final interview

After eight tumultuous years, Benoît Battistelli is no longer president of the EPO. In June, he sat down with IAM to look back on his controversial tenure. One thing was clear: he would do it the same way all over again